trovagene.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Cardiff Oncology - Cardiff |
| Description | Cardiff Oncology is a clinical-stage company with the singular mission of developing new oncology therapeutic options for cancer |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.8.82.248 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
trovagene.com Valuation
|
US$1,470
Last updated: 2023-05-12 23:27:53
trovagene.com has Semrush global rank of 0. trovagene.com has an estimated worth of US$ 1,470, based on its estimated Ads revenue. trovagene.com receives approximately 169 unique visitors each day. Its web server is located in United States, with IP address 52.8.82.248. According to SiteAdvisor, trovagene.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,470 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$40 |
| Yearly Ads Revenue | US$488 |
| Daily Unique Visitors | 11 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| trovagene.com. | A | 1799 | IP: 52.8.82.248 |
| trovagene.com. | NS | 3600 | NS Record: ns46.domaincontrol.com. |
| trovagene.com. | NS | 3600 | NS Record: ns45.domaincontrol.com. |
| trovagene.com. | MX | 1800 | MX Record: 10 trovagene-com.mail.protection.outlook.com. |
| trovagene.com. | TXT | 1800 | TXT Record: MS=F6C9FBDD290557C59BDD1831D965C4AEBDF75B3A |
| trovagene.com. | TXT | 1800 | TXT Record: google-site-verification=lgzlGkNCZuQp8Vt2zKn7g3KLHCZf0KYXcKf2GQY2J3c |
| trovagene.com. | TXT | 1800 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| trovagene.com. | TXT | 1800 | TXT Record: v=verifydomain MS=2877132 |
HtmlToTextCheckTime:2023-05-12 23:27:53
| FOR INVESTORS Stock Quote Corporate Presentation News & Events SEC Filings Governance Shareholder Services Onvansertib Pipeline Clinical Programs ONSEMBLE mCRC mCRC mPDAC Scientific Presentations Leadership Management Team Board of Directors Scientific Advisory Board Contact Us For Investors Stock Quote Corporate Presentation News & Events SEC Filings Governance Shareholder Services Cardiff Oncology Turning the Tide on Cancer Cardiff Oncology is a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers. Our lead asset is onvansertib, a PLK1 inhibitor that we are evaluating in combination with standard of care (SoC) therapeutics in clinical programs targeting indications with the greatest need for new treatment options. These programs and our broader development strategy are designed to target tumor vulnerabilities to overcome treatment resistance and deliver superior clinical benefit to patients compared to the SoC. |
HTTP Headers
HTTP/1.1 302 Moved Temporarily Server: nginx Date: Mon, 20 Dec 2021 05:55:57 GMT Content-Type: text/html Content-Length: 154 Connection: keep-alive Keep-Alive: timeout=60 Location: https://trovageneoncology.com/ |
trovagene.com Whois Information
Domain Name: TROVAGENE.COM Registry Domain ID: 1557973404_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-05-05T16:00:33Z Creation Date: 2009-06-03T16:03:25Z Registry Expiry Date: 2024-06-03T16:03:25Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS45.DOMAINCONTROL.COM Name Server: NS46.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-23T08:41:08Z <<< |